Table 2 Different distribution per year of agenesis, hypoplasia or thyroid in situ in patients with confirmed diagnosis of CH
Year | Confirmed diagnosis of CH/high TSH at the second screening | agenesis | hypoplasia | Ectopic gland | Thyroid in situ |
|---|---|---|---|---|---|
2013 | 32 (64%) | 3 (9.4%) | 7 (21.87%) | 1 (3.1%) | 21 (65.6%) |
2014 | 25 (62.5%) | 4 (16%) | 9 (36%) | 0 | 12 (48%) |
2015 | 37 (59.6%) | 2 (5.4%) | 8 (21.6%) | 0 | 27 (72.9%) |
2016 | 42 (52.5%) | 2 (4.8%) | 3 (7.1%) | 1 (2.4%) | 36 (85.7%) |
2017 | 32 (32.6%) | 0 | 5 (15.6%) | 1 (3.1%) | 26 (81.2%) |
2018 (Jan-Apr) | 14 (33.3%) | 0 | 2 (14.3%) | 1 (7.1%) | 11 (78.5%) |